CA2371942A1 - Compositions antifongiques de pseudomycine et leurs procedes d'utilisation - Google Patents

Compositions antifongiques de pseudomycine et leurs procedes d'utilisation Download PDF

Info

Publication number
CA2371942A1
CA2371942A1 CA002371942A CA2371942A CA2371942A1 CA 2371942 A1 CA2371942 A1 CA 2371942A1 CA 002371942 A CA002371942 A CA 002371942A CA 2371942 A CA2371942 A CA 2371942A CA 2371942 A1 CA2371942 A1 CA 2371942A1
Authority
CA
Canada
Prior art keywords
pseudomycin
cyclodextrin
antifungal agent
lipodepsidecapeptide
antifungal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002371942A
Other languages
English (en)
Inventor
Michael John Rodriguez
Venkatraghavan Vasudevan
Thomas Warren Jones
Stephanie Ann Sweetana
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2371942A1 publication Critical patent/CA2371942A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne des procédés et des compositions de traitement des infections fongiques contenant des préparations d'une pseudomycine ou d'un agent antifongique associé et d'une cyclodextrine. Les compositions sont particulièrement indiquées dans des applications pharmaceutiques ayant pour objectif la réduction des effets secondaires.
CA002371942A 1999-04-15 2000-04-14 Compositions antifongiques de pseudomycine et leurs procedes d'utilisation Abandoned CA2371942A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12943599P 1999-04-15 1999-04-15
US60/129,435 1999-04-15
PCT/US2000/008725 WO2000062793A2 (fr) 1999-04-15 2000-04-14 Compositions antifongiques de pseudomycine et leurs procedes d'utilisation

Publications (1)

Publication Number Publication Date
CA2371942A1 true CA2371942A1 (fr) 2000-10-26

Family

ID=22439926

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002371942A Abandoned CA2371942A1 (fr) 1999-04-15 2000-04-14 Compositions antifongiques de pseudomycine et leurs procedes d'utilisation

Country Status (11)

Country Link
EP (1) EP1171150A2 (fr)
JP (1) JP2002542201A (fr)
CN (1) CN1360505A (fr)
AU (1) AU4328700A (fr)
BR (1) BR0009778A (fr)
CA (1) CA2371942A1 (fr)
EA (1) EA200101088A1 (fr)
HU (1) HUP0201048A3 (fr)
MX (1) MXPA01010247A (fr)
NO (1) NO20014988L (fr)
WO (1) WO2000062793A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12138257B2 (en) 2008-11-15 2024-11-12 Melinta Subsidiary Corp. Antimicrobial compositions

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7034013B2 (en) * 2001-03-20 2006-04-25 Cydex, Inc. Formulations containing propofol and a sulfoalkyl ether cyclodextrin
BRPI0105509B8 (pt) * 2001-11-05 2021-05-25 Univ Minas Gerais formulações do peptídeo angiotensina-(1-7) usando as ciclodextrinas, lipossomas e o polímero plga
DE10228049A1 (de) * 2002-06-24 2004-01-15 Merck Patent Gmbh Flüssige Zubereitung enthaltend Oligopeptide
CN101578103B (zh) * 2006-06-29 2013-09-25 林科杰诺米克斯株式会社 抗生素的注射剂及其给予液
TWI568365B (zh) * 2014-07-22 2017-02-01 蘇廷弘 抑菌複合物及其製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5576298A (en) * 1992-11-30 1996-11-19 Research And Development Institute, Inc. At Montana State University Peptides from pseudomonas syringae possessing broad-spectrum antibiotic activity
US5830855A (en) * 1996-09-12 1998-11-03 Utah State University Lipodepsipeptides as antifungal and fungicidal agents

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12138257B2 (en) 2008-11-15 2024-11-12 Melinta Subsidiary Corp. Antimicrobial compositions

Also Published As

Publication number Publication date
BR0009778A (pt) 2002-01-02
CN1360505A (zh) 2002-07-24
AU4328700A (en) 2000-11-02
NO20014988L (no) 2001-12-03
HUP0201048A3 (en) 2002-10-28
MXPA01010247A (es) 2002-03-27
WO2000062793A2 (fr) 2000-10-26
EP1171150A2 (fr) 2002-01-16
NO20014988D0 (no) 2001-10-12
JP2002542201A (ja) 2002-12-10
WO2000062793A3 (fr) 2001-01-18
EA200101088A1 (ru) 2002-04-25
HUP0201048A2 (en) 2002-08-28

Similar Documents

Publication Publication Date Title
US12053502B2 (en) Daptomycin formulations
DE60103504T2 (de) Nasal verabreichbare cyclische antimykotische peptidzusammensetzungen
JP2014518878A (ja) ポリエン系殺菌剤と非リボソーム型ペプチドの相乗的組み合わせ及び関連する使用方法
WO2013100721A1 (fr) Nouveau peptide antibactérien et fongicide dans lequel les résidus de lysine et de tryptophane sont répétés quatre fois, et utilisation de celui-ci
SI9200260A (en) Lipophilic oligosaccharide antibiotic salt compostition
Balkovec Section review: Anti-infectives: Lipopeptide antifungal agents
JP5052750B2 (ja) オリゴペプチドとエーテル化シクロデキストリンを含む液体製剤
US5776912A (en) Lipophilic oligosaccharide antibiotic compositions
KR101980897B1 (ko) Ll37 펩타이드로부터 유래한 신규 항균 펩타이드 및 이의 용도
EP1171150A2 (fr) Compositions antifongiques de pseudomycine et leurs procedes d'utilisation
EP2750689A2 (fr) Dérivés d'apidaecine utilisés comme peptides antibiotiques
EP1519951B1 (fr) Peptides lineaires cationiques ayant des proprietes antifongiques
DE69212267T2 (de) Echinocandin-B-Derivat
CN1347421A (zh) 分离自丁香假单胞菌的抗真菌剂
JPH0742315B2 (ja) アミノアルキルチオエーテル化合物
US7795207B2 (en) Lipopeptide compositions
EP0821004A1 (fr) Nouveaux peptides et medicaments pour les maladies osseuses contenant ces peptides comme ingredient actif
US6143726A (en) Complexes of N'-dimethylaminoacetylpartricin A dimethylaminoethylamide, or the salts thereof, and cholesterol 3-sulphate
US6630147B1 (en) Pseudomycin natural products
EP1453855B1 (fr) Peptides bolisine antimicrobiens
WO2007057005A1 (fr) Compositions a base de lipopeptide
Zeng et al. The discovery of novel antimicrobial peptides against multidrug-resistant bacteria based on thioether cyclization and unnatural amino acid incorporation strategies
KR20020051124A (ko) 부포린 유도체를 포함하는 함암제
DE10160170A1 (de) Neue antimikrobielle Bolisinpeptide
EP1994938A1 (fr) Nouvelles compositions de lipoglycodepsipeptide

Legal Events

Date Code Title Description
FZDE Discontinued